IBDEI0V6 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15375,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,15375,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,15376,0)
 ;;=V13.01^^89^905^36
 ;;^UTILITY(U,$J,358.3,15376,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15376,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,15376,1,5,0)
 ;;=5^Hx of Kidney Stones
 ;;^UTILITY(U,$J,358.3,15376,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,15377,0)
 ;;=V12.51^^89^905^59
 ;;^UTILITY(U,$J,358.3,15377,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15377,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,15377,1,5,0)
 ;;=5^Hx of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,15377,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,15378,0)
 ;;=V17.89^^89^905^18
 ;;^UTILITY(U,$J,358.3,15378,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15378,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,15378,1,5,0)
 ;;=5^Family h/o Musculosk Disease
 ;;^UTILITY(U,$J,358.3,15378,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,15379,0)
 ;;=V12.54^^89^905^56
 ;;^UTILITY(U,$J,358.3,15379,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15379,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,15379,1,5,0)
 ;;=5^Hx of TIA
 ;;^UTILITY(U,$J,358.3,15379,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,15380,0)
 ;;=V12.54^^89^905^52
 ;;^UTILITY(U,$J,358.3,15380,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15380,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,15380,1,5,0)
 ;;=5^Hx of Stroke w/o Residual
 ;;^UTILITY(U,$J,358.3,15380,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,15381,0)
 ;;=V15.88^^89^905^33
 ;;^UTILITY(U,$J,358.3,15381,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15381,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,15381,1,5,0)
 ;;=5^Hx of Fall(s)
 ;;^UTILITY(U,$J,358.3,15381,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,15382,0)
 ;;=V13.59^^89^905^42
 ;;^UTILITY(U,$J,358.3,15382,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15382,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,15382,1,5,0)
 ;;=5^Hx of Musculosk Disease
 ;;^UTILITY(U,$J,358.3,15382,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,15383,0)
 ;;=V15.52^^89^905^55
 ;;^UTILITY(U,$J,358.3,15383,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15383,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,15383,1,5,0)
 ;;=5^Hx of TBI
 ;;^UTILITY(U,$J,358.3,15383,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,15384,0)
 ;;=V12.04^^89^905^38
 ;;^UTILITY(U,$J,358.3,15384,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15384,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,15384,1,5,0)
 ;;=5^Hx of MRSA Infection
 ;;^UTILITY(U,$J,358.3,15384,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,15385,0)
 ;;=V13.51^^89^905^23
 ;;^UTILITY(U,$J,358.3,15385,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15385,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,15385,1,5,0)
 ;;=5^Hs of Pathological Fx
 ;;^UTILITY(U,$J,358.3,15385,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,15386,0)
 ;;=V15.51^^89^905^58
 ;;^UTILITY(U,$J,358.3,15386,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15386,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,15386,1,5,0)
 ;;=5^Hx of Traumatic Fx
 ;;^UTILITY(U,$J,358.3,15386,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,15387,0)
 ;;=V62.22^^89^905^49
 ;;^UTILITY(U,$J,358.3,15387,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15387,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,15387,1,5,0)
 ;;=5^Hx of Return from Military Deployment
 ;;^UTILITY(U,$J,358.3,15387,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,15388,0)
 ;;=919.1^^89^906^1
 ;;^UTILITY(U,$J,358.3,15388,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15388,1,4,0)
 ;;=4^919.1
 ;;^UTILITY(U,$J,358.3,15388,1,5,0)
 ;;=5^Abrasion, Infected
 ;;^UTILITY(U,$J,358.3,15388,2)
 ;;=^275358
 ;;^UTILITY(U,$J,358.3,15389,0)
 ;;=919.0^^89^906^2
